NRC Health (NASDAQ: NRC) Stock Competitors & Peer Comparison
See NRC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NRC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NRC | $21.31 | +3.40% | 480.3M | 25.99 | $0.82 | +2.82% |
| GEHC | $73.79 | +2.09% | 33.3B | 16.18 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $60.23 | +0.92% | 11.8B | 48.57 | $1.24 | N/A |
| TEM | $54.29 | -0.59% | 9.5B | -108.58 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.59 | +0.09% | 8.8B | 24.67 | $4.28 | N/A |
| TXG | $58.15 | +0.69% | 7.4B | -342.06 | -$0.17 | N/A |
| HNGE | $87.42 | +1.27% | 6.8B | 46.68 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NRC vs GEHC Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, GEHC has a market cap of 33.3B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while GEHC trades at $73.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas GEHC's P/E ratio is 16.18. In terms of profitability, NRC's ROE is +0.48%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, NRC is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NRC vs GEHCV Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, NRC is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NRC vs BTSG Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while BTSG trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas BTSG's P/E ratio is 48.57. In terms of profitability, NRC's ROE is +0.48%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, NRC is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NRC vs TEM Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, TEM has a market cap of 9.5B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while TEM trades at $54.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas TEM's P/E ratio is -108.58. In terms of profitability, NRC's ROE is +0.48%, compared to TEM's ROE of -0.55%. Regarding short-term risk, NRC is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
NRC vs SGFY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NRC's ROE is +0.48%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NRC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NRC vs HQY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HQY trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HQY's P/E ratio is 24.67. In terms of profitability, NRC's ROE is +0.48%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NRC is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
NRC vs TXG Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while TXG trades at $58.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas TXG's P/E ratio is -342.06. In terms of profitability, NRC's ROE is +0.48%, compared to TXG's ROE of -0.09%. Regarding short-term risk, NRC is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
NRC vs HNGE Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HNGE trades at $87.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HNGE's P/E ratio is 46.68. In terms of profitability, NRC's ROE is +0.48%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, NRC is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for NRC.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
NRC vs RCM Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas RCM's P/E ratio is -102.21. In terms of profitability, NRC's ROE is +0.48%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NRC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
NRC vs DOCS Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while DOCS trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas DOCS's P/E ratio is 17.38. In terms of profitability, NRC's ROE is +0.48%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, NRC is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
NRC vs WAY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while WAY trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas WAY's P/E ratio is 16.61. In terms of profitability, NRC's ROE is +0.48%, compared to WAY's ROE of +0.04%. Regarding short-term risk, NRC is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NRC vs ONEM Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NRC's ROE is +0.48%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NRC is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NRC vs PRVA Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while PRVA trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas PRVA's P/E ratio is 103.62. In terms of profitability, NRC's ROE is +0.48%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, NRC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NRC vs HTFL Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HTFL has a market cap of 2.7B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HTFL trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HTFL's P/E ratio is -15.43. In terms of profitability, NRC's ROE is +0.48%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, NRC is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
NRC vs WGS Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while WGS trades at $79.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas WGS's P/E ratio is 219.86. In terms of profitability, NRC's ROE is +0.48%, compared to WGS's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for NRC.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
NRC vs PGNY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while PGNY trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas PGNY's P/E ratio is 18.76. In terms of profitability, NRC's ROE is +0.48%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, NRC is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
NRC vs NXGN Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas NXGN's P/E ratio is -266.00. In terms of profitability, NRC's ROE is +0.48%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, NRC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
NRC vs OMDA Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while OMDA trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas OMDA's P/E ratio is 348.14. In terms of profitability, NRC's ROE is +0.48%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, NRC is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
NRC vs AGTI Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NRC's ROE is +0.48%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NRC vs GDRX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while GDRX trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas GDRX's P/E ratio is 11.63. In terms of profitability, NRC's ROE is +0.48%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NRC is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
NRC vs CERT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CERT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CERT's P/E ratio is 20.38. In terms of profitability, NRC's ROE is +0.48%, compared to CERT's ROE of -0.07%. Regarding short-term risk, NRC is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CERT's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NRC vs TDOC Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while TDOC trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas TDOC's P/E ratio is -7.72. In terms of profitability, NRC's ROE is +0.48%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, NRC is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NRC vs CCLDO Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NRC vs HSTM Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HSTM has a market cap of 847.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HSTM trades at $29.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HSTM's P/E ratio is 35.83. In terms of profitability, NRC's ROE is +0.48%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NRC is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
NRC vs PHR Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, PHR has a market cap of 779.4M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas PHR's P/E ratio is 45.04. In terms of profitability, NRC's ROE is +0.48%, compared to PHR's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for NRC.Check PHR's competition here
Claritev Corporation (NYSE: CTEV)
NRC vs CTEV Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CTEV has a market cap of 719.4M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CTEV trades at $42.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CTEV's P/E ratio is -2.48. In terms of profitability, NRC's ROE is +0.48%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NRC vs SOPH Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SOPH has a market cap of 639.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SOPH trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SOPH's P/E ratio is -6.86. In terms of profitability, NRC's ROE is +0.48%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, NRC is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NRC vs MPLN-WT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
NRC vs ACCD Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NRC's ROE is +0.48%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NRC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for NRC.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NRC vs SHCR Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NRC's ROE is +0.48%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NRC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
NRC vs EVH Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, EVH has a market cap of 525.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while EVH trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas EVH's P/E ratio is 35.92. In terms of profitability, NRC's ROE is +0.48%, compared to EVH's ROE of -0.99%. Regarding short-term risk, NRC is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NRC vs SLGCW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NRC's ROE is +0.48%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NRC vs SLGC Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NRC's ROE is +0.48%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NRC is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NRC vs TBRG Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NRC's ROE is +0.48%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NRC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
NRC vs MPLN Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NRC's ROE is +0.48%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, NRC is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
NRC vs SY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SY has a market cap of 288.7M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SY trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SY's P/E ratio is -6.67. In terms of profitability, NRC's ROE is +0.48%, compared to SY's ROE of -0.16%. Regarding short-term risk, NRC is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NRC vs TRHC Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NRC's ROE is +0.48%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NRC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for NRC.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NRC vs SMFR Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SMFR's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NRC vs SPOK Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SPOK has a market cap of 229.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SPOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SPOK's P/E ratio is 18.33. In terms of profitability, NRC's ROE is +0.48%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, NRC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
NRC vs AMWL Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, AMWL has a market cap of 219.9M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while AMWL trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas AMWL's P/E ratio is -2.93. In terms of profitability, NRC's ROE is +0.48%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, NRC is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NRC vs OPRX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while OPRX trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas OPRX's P/E ratio is 8.06. In terms of profitability, NRC's ROE is +0.48%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, NRC is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NRC vs CPSI Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NRC's ROE is +0.48%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NRC is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NRC vs HCAT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HCAT trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HCAT's P/E ratio is 8.75. In terms of profitability, NRC's ROE is +0.48%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, NRC is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NRC vs AUGX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NRC's ROE is +0.48%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NRC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NRC vs CCLD Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CCLD's P/E ratio is 9.42. In terms of profitability, NRC's ROE is +0.48%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
NRC vs WORX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas WORX's P/E ratio is -6.40. In terms of profitability, NRC's ROE is +0.48%, compared to WORX's ROE of -0.65%. Regarding short-term risk, NRC is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
NRC vs FORA Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas FORA's P/E ratio is -24.11. In terms of profitability, NRC's ROE is +0.48%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NRC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for NRC.Check FORA's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NRC vs DH Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, DH has a market cap of 67.6M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while DH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas DH's P/E ratio is 2.46. In terms of profitability, NRC's ROE is +0.48%, compared to DH's ROE of -0.75%. Regarding short-term risk, NRC is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NRC vs CCLDP Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NRC vs ONMD Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ONMD has a market cap of 44.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ONMD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ONMD's P/E ratio is -5.18. In terms of profitability, NRC's ROE is +0.48%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, NRC is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NRC vs SNCE Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NRC's ROE is +0.48%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NRC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NRC vs AKLI Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NRC's ROE is +0.48%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NRC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NRC vs SHLT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NRC's ROE is +0.48%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NRC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NRC vs SHCRW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.48%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NRC is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NRC vs ONMDW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ONMDW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, NRC is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NRC vs STRM Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas STRM's P/E ratio is -2.40. In terms of profitability, NRC's ROE is +0.48%, compared to STRM's ROE of -0.65%. Regarding short-term risk, NRC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for NRC.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NRC vs RNLX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NRC's ROE is +0.48%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NRC is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NRC vs LIFW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.48%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
NRC vs SCNX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SCNX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SCNX's P/E ratio is -0.19. In terms of profitability, NRC's ROE is +0.48%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, NRC is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
NRC vs BBLN Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +0.48%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NRC is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
NRC vs BEATW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, BEATW has a market cap of 12.5M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas BEATW's P/E ratio is -0.03. In terms of profitability, NRC's ROE is +0.48%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, NRC is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NRC vs BFRG Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas BFRG's P/E ratio is -1.08. In terms of profitability, NRC's ROE is +0.48%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, NRC is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for NRC.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NRC vs ETAO Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +0.48%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NRC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NRC vs MGRX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MGRX's P/E ratio is -0.39. In terms of profitability, NRC's ROE is +0.48%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, NRC is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
NRC vs UPH Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas UPH's P/E ratio is -0.07. In terms of profitability, NRC's ROE is +0.48%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NRC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NRC vs UPH-WT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, NRC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for NRC.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NRC vs PEARW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.48%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NRC vs PEAR Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NRC's ROE is +0.48%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for NRC.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NRC vs OTRK Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NRC's ROE is +0.48%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NRC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for NRC.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NRC vs HCTI Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while HCTI trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas HCTI's P/E ratio is -0.22. In terms of profitability, NRC's ROE is +0.48%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, NRC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for NRC.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
NRC vs CMAX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.48%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NRC vs VSEEW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, NRC's ROE is +0.48%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, NRC is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check VSEEW's competition here
Aclarion, Inc. (NASDAQ: ACON)
NRC vs ACON Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ACON's P/E ratio is -0.27. In terms of profitability, NRC's ROE is +0.48%, compared to ACON's ROE of -0.59%. Regarding short-term risk, NRC is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NRC vs LIFWZ Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
NRC vs EUDAW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, NRC's ROE is +0.48%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, NRC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NRC vs VSEE Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas VSEE's P/E ratio is -0.10. In terms of profitability, NRC's ROE is +0.48%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, NRC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for NRC.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NRC vs MSPRZ Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, NRC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
NRC vs KERN Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas KERN's P/E ratio is -0.01. In terms of profitability, NRC's ROE is +0.48%, compared to KERN's ROE of -0.20%. Regarding short-term risk, NRC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
NRC vs KERNW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.48%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, NRC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NRC vs LIFWW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, NRC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NRC vs CMAXW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NRC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NRC vs ZCMD Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ZCMD has a market cap of 35.3K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ZCMD trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, NRC's ROE is +0.48%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, NRC is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NRC vs ACONW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas ACONW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, NRC is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
NRC vs WGSWW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, NRC's ROE is +0.48%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, NRC is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for NRC.Check WGSWW's competition here
Cerner Corporation (NASDAQ: CERN)
NRC vs CERN Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CERN has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CERN's P/E ratio is 55.84. In terms of profitability, NRC's ROE is +0.48%, compared to CERN's ROE of +0.14%. Regarding short-term risk, NRC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NRC vs CHNGU Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNGU's competition here
Castlight Health, Inc. (NYSE: CSLT)
NRC vs CSLT Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CSLT's P/E ratio is -37.27. In terms of profitability, NRC's ROE is +0.48%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, NRC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CSLT's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
NRC vs IMS Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, IMS has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas IMS's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to IMS's ROE of +0.27%. Regarding short-term risk, NRC is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for NRC.Check IMS's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
NRC vs CHNG Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CHNG's P/E ratio is -152.72. In terms of profitability, NRC's ROE is +0.48%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, NRC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NRC vs MTBCO Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCO's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NRC vs MTBCP Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, NRC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for NRC.Check MTBCP's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
NRC vs CNVY Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas CNVY's P/E ratio is -71.50. In terms of profitability, NRC's ROE is +0.48%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, NRC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for NRC.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NRC vs MTBC Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MTBC's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, NRC is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MTBC's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
NRC vs KURIU Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas KURIU's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, NRC is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for NRC.Check KURIU's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NRC vs MSPRV Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NRC is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for NRC.Check MSPRV's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
NRC vs NAVA Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas NAVA's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, NRC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for NRC.Check NAVA's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
NRC vs SMFRW Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas SMFRW's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, NRC is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for NRC.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
NRC vs NH Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, NH has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas NH's P/E ratio is -0.12. In terms of profitability, NRC's ROE is +0.48%, compared to NH's ROE of +0.35%. Regarding short-term risk, NRC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for NRC.Check NH's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
NRC vs AFFX Comparison August 2026
NRC Health (NASDAQ: NRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NRC stands at 480.3M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, NRC is priced at $21.31 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NRC currently has a P/E ratio of 25.99, whereas AFFX's P/E ratio is N/A. In terms of profitability, NRC's ROE is +0.48%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, NRC is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for NRC.Check AFFX's competition here